1222
D. Patra et al. / Polymer 53 (2012) 1219e1228
times with ethyl acetate. The combined organic fractions were
washed with brine, dried over magnesium sulphate (MgSO4), and
concentrated by rotary evaporation and purified by column chro-
matography, (hexane: ethyl acetate ¼ 7:3) to give a white solid.
2.4.6. 4,40-(9-(Tridecan-7-yl)-9H-carbazole-2,7-diyl)bis(2-
methylbut-3-yn-2-ol) (6)
To a solution of 2,7-dibromo-9-(tridecan-7-yl)-9H-carbazole (5)
(5.0 g, 9.84 mmol) in 50 ml of THF/Et3N (1/1), 3-methyl-1-butyn-3-
ol (3.85 ml, 39.37 mmol), Pd(PPh3)2Cl2 (0.13 g, 0.28 mol), PPh3
(0.1 g, 0.39 mol), and CuI (0.07 g, 0.39 mmol) were added. The
reaction mixture was degassed with nitrogen for 30 min, and
refluxed at 70 ꢀC under N2 for 12 h. The solvent was removed under
reduced pressure and resulting solid was extracted with DCM then
dried over MgSO4. The crude product was purified by column
chromatograph (hexane: ethyl acetate ¼ 4:1) to afford a white solid
(10.70 g, yield 87%). 1H NMR (300 MHz, CDCl3,
d):7.45e7.41 (m, 4H),
7.35e7.33 (m, 2H), 7.30e7.27 (m, 4H),4.84 (br, 2H), 3.34e3.11(br,
4H), 1.43e1.25 (m, 8H), 0.88 (t, J ¼ 6.2 Hz, 6H). 13C NMR (75 MHz,
CDCl3,
14.03.
d): 166.49, 144.61, 128.62, 128.28, 125.28, 40.57, 32.15, 20.25,
2.4.3. N2,N2-bis(4-bromophenyl)-N4,N6-dibutyl-1,3,5-triazine-
2,4,6-triamine (M1)
(3.9 g, 77%). 1H NMR (300 MHz, CDCl3,
d
): 7.97 (t, J ¼ 9.0, 2H), 7.65 (s,
N-Bromosuccinimide (NBS) (6.9 g, 38.40 mmol) was added
portion-wise to a solution of compound 2 (5.0 g, 12.80 mmol) in
af (50 ml) at 0 ꢀC. The reaction mixture was stirred for 6 h at the
same temperature and water was added to quench the reaction.
The organic layer was extracted three times by ethyl acetate
followed by brine and water washing and dried over anhydrous
MgSO4. The solvent was removed by rotary evaporator and the
product was further purified by column chromatography
(hexane: ethyl acetate ¼ 4:1) to yield a white solid. (5.7 g, 80%).
1H), 7.47 (s, 1H), 7.30 (m, 2H), 4.48 (m, 1H), 2.29e2.17 (m, 2H),
1.95e1.87 (m, 2H), 1.67 (s, 12H), 1.28e0.1.08 (m, 16H), 0.80 (t,
J ¼ 6.6 Hz, 6H).13C NMR (75 MHz, CDCl3,
d): 144.42, 131.05, 130.49,
124.29, 117.02,115.25, 93.91, 84.23, 81.55, 65.88, 65.78, 47.83, 33. 80,
31.81, 29.20, 27.10, 22.70, 14.20.
2.4.7. 2,7-Diethynyl-9-(tridecan-7-yl)-9H-carbazole (7)
A mixture of compound 6 (3.5 g, 6.81 mmol) and KOH
(2.70 mg, 47.68 mmol) in 60 ml of 2-propanol was heated to
reflux under N2 with a vigorous stirring for 4 h. Solvent was
removed and then the crude product was purified by column
chromatography (hexane) to afford a white solid (1.90 g, 70%). 1H
1H NMR (300 MHz, CDCl3,
d): 7.47e7.38 (m, 4H), 7.43e7.28 (m,
4H), 4.84 (br, 2H), 3.34e3.31(br, 4H), 1.43e1.25 (m, 8H), 0.88 (t,
J ¼ 6.2 Hz, 6H). 13C NMR (75 MHz, CDCl3,
d): 166.48, 166.11,
143.25, 131.81, 129.77, 118.79, 40.60, 32.09, 20.24, 14.01; EIMS
NMR (300 MHz, CDCl3,
d
): 8.01 (t, J ¼ 9.0, 2H), 7.72 (s, 1H), 7.56 (s,
[Mþ] calcd. m/z
¼
548.32, found 548.0. Anal. Calcd. for
1H), 7.35 (d, 2H), 4.48 (m, 1H), 3.15 (s, 1H), 2.30e2.17 (m, 2H),
1.97e1.87 (m, 2H), 1.25e1.04 (m, 16H), 0.80 (t, J ¼ 6.6 Hz, 6H). 13C
C23H28Br2N6: C, 50.38; H, 5.15; Br, 29.15; N, 15.33; found: C,
50.78; H, 5.48; N, 15.04.
NMR (75 MHz, CDCl3, d): 142.27, 138.43, 124.08, 123.21, 122.65,
120.82, 119.58, 115.67, 113.18, 85.27, 57.10, 33.89, 31.78, 29.25,
27.02, 22.73, 14.19.
2.4.4. 1-Hexyluracil (3)
Potassium carbonate (K2CO3) (14.80 g, 107.05 mmol) was added
to a suspension of uracil (10.0 g, 89.21 mmol) in dimethyl sulf-
oxide (DMSO) (150 ml), and stirred for 15e20 min at 45 ꢀC. 1-
Bromohexane (3.5 ml, 25 mmol) was added and the reaction
mixture was stirred for 48 h. The reaction was cooled to room
temperature and poured into cold water. The product was
extracted three times with dichloromethane (DCM), and washed
with dilute HCl, water, brine, and dried over MgSO4. The organic
layer was concentrated and poured into cold hexane with vigorous
stirring. The resulting precipitate was filtered and washed with
cold hexane to afford compound 3 (12.40 g, 70.9%) as a white solid.
2.4.8. 6,60-(9-(Tridecan-7-yl)-9H-carbazole-2,7-diyl)bis(ethyne-
2,1-diyl)bis(1-hexylpyrimidine-2,4(1H,3H)-dione) (C)
To a mixture of compound 7 (0.5 g, 1.26 mmol) in 20 ml THF/
NEt3 (1:1), compound 4 (1.22 g, 3.77 mmol), triphenylphosphine
(13 mg, 0.05), and CuI (10 mg, 0.05 mmol) were added. [Pd(PPh2)
Cl2] (36 mg, 0.05 mmol) was added under N2 and then the reaction
mixture was heated at 50 ꢀC for 36 h. The crude product was
extracted with DCM followed by brine wash and dried over MgSO4.
The resulting solutions were concentrated by rotary evaporator,
and purified by column chromatography, (hexane:ethyl acetate 7:3)
to give a light yellow solid. (0.60 g, yield 60%). 1H NMR (300 MHz,
1H NMR (300 MHz, CDCl3,
d
): 9.12 (br, 1H), 7.14 (d, J ¼ 9.0 Hz, 1H),
5.70 (d, J ¼ 6.0 Hz, 1H), 3.71(t, J ¼ 7.5 Hz, 2H), 1.74e1.65 (m, 2H),
CDCl3, d): 9.04 (br, 2H), 8.04 (m, 2H), 7.69 (s, 1H), 7.54 (s, 1H), 7.32
1.34e1.27 (m, 6H), 0.88 (t, J ¼ 6.6 Hz, 3H).13C NMR (75 MHz, CDCl3,
(m, 2H), 6.0 (s, 2H), 4.48 (m, 1H), 4.06 (t, J ¼ 6.0 Hz, 4H), 2.20 (m,
2H), 1.97 (m, 2H), 1.77 (m, 4H), 1.64 (m, 4H), 1.36e1.52 (m, 10H),
1.42e0.92 (m, 14H), 0.80 (t, J ¼ 6.9 Hz, 6H), 0.71 (t, J ¼ 6.2, 6H). 13C
d
): 165.24; 150.55; 144.80; 100.75; 48.67; 31.79; 28.26; 25.61;
22.48; 13.91.
NMR (75 MHz, CDCl3, d): 161.50, 156.79, 149.67, 137.77, 122.65,
2.4.5. 1-Hexyl-6-iodouracil (4)
121.97, 120.45, 114.39, 111.98, 105.50, 100.79, 79.45, 56.26, 45.75,
32.75, 30.50, 30.45, 29.27, 28.67, 27.96, 27.82, 25.78, 25.49, 21.57,
21.44, 12.96; EIMS [Mþ] calcd. m/z ¼ 786.06, found 787.0. Anal.
Calcd. For C49H62N4O4: C, 74.87; H, 8.08; N, 8.91; O, 8.14; found: C,
74.68; H, 7.97; N, 8.77.
At ꢂ78 ꢀC, lithium diisopropylamide (LDA) (20.4 ml of a 2.5 M
solution, 51.0 mmol) was added drop-wise to a solution of 1-
hexyluracil (2.0 g, 10.2 mmol) in THF (55 ml), and the resulting
solution was stirred under N2 for 2 h. I2 (12.9 g, 51.0 mmol) was
added and the reaction mixture was stirred for another 2 h at the
same temperature. Acetic acid (2.0 ml) was added under stirring at
room temperature overnight. The organic phase was extracted
with ethyl acetate, washed with saturated NaHCO3 (3 ꢁ 30.0 ml)
and Na2SO3 (3 ꢁ 30 ml) solutions. Finally, the product was washed
with brine (30 ml), and dried over MgSO4. The solvent was
removed by rotary evaporator and the crude product was purified
by column chromatography (hexane: ethyl acetate ¼ 5:5) to afford
2.4.9. 6,60-(9,9-Dihexyl-9H-fluorene-2,7-diyl)bis(ethyne-2,1-diyl)
bis(1-hexylpyrimidine-2,4(1H,3H)-dione) (F)
The synthesis procedure for F was followed using the same
procedure as that of C. After purification (hexane:ethyl acetate 7:3)
afforded a light yellow solid. (0.58 g, yield 58%). 1H NMR (300 MHz,
CDCl3,
d
): 9.60 (br, 2H), 7.77 (d, J ¼ 8.1 Hz, 2H), 7.53 (m, 4H), 6.04 (m,
2H) 4.01 (t, J ¼ 7.8 Hz, 4H), 2.0 (t, J ¼ 8.1 Hz, 4H), 1.82 (t, J ¼ 7.2 Hz,
4H), 1.44e1.34 (m, 12H), 1.36e1.08 (m, 12H), 1.15e1.08 (m, 12H),
0.88 (t, J ¼ 6.9 Hz, 6H), 0.77 (t, J ¼ 7.2, 6H), 0.59 (m, 4H). 13C NMR
compound 4 (2.2 g, 67%). 1H NMR (300 MHz, CDCl3,
d): 9.48 (br,
1H), 6.41 (s, 1H), 4.0 (t, J ¼ 8.1 Hz, 2H), 1.74e1.65 (m, 2H), 1.34e1.27
(m, 6H), 0.88 (t, J ¼ 6.9 Hz, 3H).13C NMR (75 MHz, CDCl3,
d
):
(75 MHz, CDCl3, d): 162.96, 151.95, 151.08, 142.41, 138.89, 131.72,
160.65; 148.19; 115.91; 113.52; 53.48; 31.36; 27.45; 26.32; 22.17;
14.18.
126.58, 121.05, 119.76, 106.89, 101.28, 81.30, 55.84, 46.94, 40.31,
31.67, 29.77, 29.02, 26.65, 23.97, 22.77, 22.75, 14.19; EIMS [Mþ]